Author/Authors :
Hosseini, Forough Department of Medicine - Division of General Internal Medicine - Toronto General Hospital, Toronto, Canada , Behnam- Roudsari, Sahar Department of Medicine - Division of General Internal Medicine - Toronto General Hospital, Toronto, Canada , Alavinia, Ghazal Department of Medicine - Division of General Internal Medicine - Toronto General Hospital, Toronto, Canada , Emami, Anahita Department of Medicine - Division of General Internal Medicine - Toronto General Hospital, Toronto, Canada , Toghyani, Arash Department of Internal Medicine - School of Medicine - Isfahan University of Medical Sciences, Isfahan, Iran , Moradi, Sanaz Department of Medicine - Division of General Internal Medicine - Toronto General Hospital, Toronto, Canada , Mojtahed Zadeh, Mahtab Department of Medicine - Division of General Internal Medicine - Toronto General Hospital, Toronto, Canada , Mohseni, Sana Department of Medicine - Division of General Internal Medicine - Toronto General Hospital, Toronto, Canada , Shafiee, Mohammad Ali Department of Medicine - Division of General Internal Medicine - Toronto General Hospital, Toronto, Canada
Abstract :
Background: The coronavirus disease 2019 (COVID‑19) presents various phenotypes from asymptomatic involvement to
death. Disseminated intravascular coagulopathy (DIC) is among the poor prognostic complications frequently observed in
critical illness. To improve mortality, a timely diagnosis of DIC is essential. The International Society on Thrombosis and
Hemostasis (ISTH) introduced a scoring system to detect overt DIC (score ≥5) and another category called sepsis‑induced
coagulopathy (SIC) to identify the initial stages of DIC (score ≥4). This study aimed to determine whether clinicians used
these scoring systems while assessing COVID‑19 patients and the role of relevant biomarkers in disease severity and outcome.
Materials and Methods: An exhaustive search was performed according to Preferred Reporting Items for Systematic Reviews
and Meta‑Analyses, using Medline, Embase, Cochrane, CINAHL, and PubMed until August 2020. Studies considering disease
severity or outcome with at least two relevant biomarkers were included. For all studies, the definite, maximum, and minimum
ISTH/SIC scores were calculated. Results: A total of 37 papers and 12,463 cases were reviewed. Studies considering ISTH/SIC
criteria to detect DIC suggested a higher rate of ISTH ≥5 and SIC ≥4 in severe cases and nonsurvivors compared with nonsevere
cases and survivors. The calculated ISTH scores were dominantly higher in severe infections and nonsurvivors. Elevated D‑dimer
was the most consistent abnormality on admission. Conclusion: Higher ISTH and SIC scores positively correlate with disease
severity and death. In addition, more patients with severe disease and nonsurvivors met the ISTH and SIC scores for DIC.
Given the high prevalence of coagulopathy in COVID‑19 infection, dynamic monitoring of relevant biomarkers in the form of
ISTH and SIC scoring systems is of great importance to timely detect DIC in suspicious patients.
Keywords :
Coagulopathy , coronavirus disease 2019 , disseminated intravascular coagulation , International Society on Thrombosis and Hemostasis , sepsis‑induced coagulopathy score